Gene: TBC1D25
Official Full Name: TBC1 domain family member 25provided by HGNC
Gene Summary: This gene encodes a protein with a TBC domain and functions as a Rab GTPase activating protein. The encoded protein is involved in the fusion of autophagosomes with endosomes and lysosomes. This gene was previously known as ornithine aminotransferase-like 1, but has no similarity to ornithine aminotransferase. [provided by RefSeq, Jan 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36271 | TBC1D25 Knockout cell line (HeLa) | Human | TBC1D25 | 1:3~1:6 | Negative | Online Inquiry |
KO36272 | TBC1D25 Knockout cell line (HCT 116) | Human | TBC1D25 | 1:2~1:4 | Negative | Online Inquiry |
KO36273 | TBC1D25 Knockout cell line (HEK293) | Human | TBC1D25 | 1:3~1:6 | Negative | Online Inquiry |
KO36274 | TBC1D25 Knockout cell line (A549) | Human | TBC1D25 | 1:3~1:4 | Negative | Online Inquiry |
TBC1D25 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the TBC1D25 gene's roles in various biological processes, particularly those related to cellular signaling and metabolism. This product features a precise knockout of the TBC1D25 gene, achieved through advanced CRISPR-Cas9 technology, allowing for controlled investigations into the gene's functions and interactions in a cellular context.
These cell lines serve as invaluable tools for researchers aiming to decipher the mechanisms by which TBC1D25 influences cellular homeostasis and metabolic pathways. Upon knockout of the TBC1D25 gene, researchers can observe alterations in cell proliferation, migration, and response to stress, providing insights into its potential implications in diseases such as obesity, diabetes, and various forms of cancer. The ability to study TBC1D25 in isolation from its normal function offers a unique perspective that can lead to breakthroughs in understanding disease mechanisms and identifying therapeutic targets.
One of the primary advantages of TBC1D25 Gene Knockout Cell Lines is their specificity and reliability, offering higher confidence in experimental outcomes compared to traditional siRNA knockdown approaches. The stable knockout ensures consistent phenotype expression, making these cell lines suitable for both short-term and long-term studies. Additionally, they can be utilized in various experimental platforms, including drug screening and gene interaction studies, further enhancing their versatility in scientific research.
For researchers and clinicians, the TBC1D25 Gene Knockout Cell Lines are of immense value. They enable the dissection of complex biological pathways with unprecedented precision, ultimately contributing to the developing landscape of targeted therapies and personalized medicine. Our company prides itself on its expertise in genetic engineering and the development of innovative biological tools, ensuring that researchers have access to high-quality, reliable products that advance their work in understanding and treating complex human diseases.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.